Search research articles
Contact Us
Filters
Showing results (21-30 of 30) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 30 results.
Proceedings of the National Academy of Sciences of the United States of America
|
March 30, 2006
FRA1 is a determinant for the difference in RAS-induced transformation between human and rat fibroblasts
Kyoko Kakumoto, Ken Sasai, Taiko Sukezane, et al.
Oncogene
|
August 17, 2005
Induction of p21(WAF1/CIP1) by human synovial sarcoma-associated chimeric oncoprotein SYT-SSX1
Masumi Tsuda, Takuya Watanabe, Tatsuya Seki, et al.
Molecular and Cellular Biology
|
August 4, 2010
mDia1 targets v-Src to the cell periphery and facilitates cell transformation, tumorigenesis, and invasion
Masahiro Tanji, Toshimasa Ishizaki, Saman Ebrahimi, et al.
Oncogene
|
September 21, 2004
Loss of c-abl facilitates anchorage-independent growth of p53- and RB- deficient primary mouse embryonic fibroblasts
Jun Suzuki, Taiko Sukezane, Tsuyoshi Akagi, et al.
Cancer Research
|
September 9, 2017
Transplantation of iPS-Derived Tumor Cells with a Homozygous MHC Haplotype Induces GRP94 Antibody Production in MHC-Matched Macaques
Hirohito Ishigaki, Toshinaga Maeda, Hirokazu Inoue, et al.
Cancer Science
|
September 5, 2017
Antitumor effects of eribulin depend on modulation of the tumor microenvironment by vascular remodeling in mouse models
Ken Ito, Shusei Hamamichi, Takanori Abe, et al.
The Journal of Cell Biology
|
June 2, 2010
Laminin-based cell adhesion anchors microtubule plus ends to the epithelial cell basal cortex through LL5alpha/beta
Azusa Hotta, Tomomi Kawakatsu, Tomoya Nakatani, et al.
Nature Communications
|
March 12, 2024
Delivery of a BET protein degrader via a CEACAM6-targeted antibody-drug conjugate inhibits tumour growth in pancreatic cancer models
Youya Nakazawa, Masayuki Miyano, Shuntaro Tsukamoto, et al.
Scientific Reports
|
June 19, 2019
A landmark in drug discovery based on complex natural product synthesis
Satoshi Kawano, Ken Ito, Kenzo Yahata, et al.
Molecular Cancer Therapeutics
|
October 24, 2022
ER-851, a Novel Selective Inhibitor of AXL, Overcomes Resistance to Antimitotic Drugs
Shuntaro Tsukamoto, Naoko Hata Sugi, Kyoko Nishibata, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 30) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 30 results.
Proceedings of the National Academy of Sciences of the United States of America
|
March 30, 2006
FRA1 is a determinant for the difference in RAS-induced transformation between human and rat fibroblasts
Kyoko Kakumoto, Ken Sasai, Taiko Sukezane, et al.
Oncogene
|
August 17, 2005
Induction of p21(WAF1/CIP1) by human synovial sarcoma-associated chimeric oncoprotein SYT-SSX1
Masumi Tsuda, Takuya Watanabe, Tatsuya Seki, et al.
Molecular and Cellular Biology
|
August 4, 2010
mDia1 targets v-Src to the cell periphery and facilitates cell transformation, tumorigenesis, and invasion
Masahiro Tanji, Toshimasa Ishizaki, Saman Ebrahimi, et al.
Oncogene
|
September 21, 2004
Loss of c-abl facilitates anchorage-independent growth of p53- and RB- deficient primary mouse embryonic fibroblasts
Jun Suzuki, Taiko Sukezane, Tsuyoshi Akagi, et al.
Cancer Research
|
September 9, 2017
Transplantation of iPS-Derived Tumor Cells with a Homozygous MHC Haplotype Induces GRP94 Antibody Production in MHC-Matched Macaques
Hirohito Ishigaki, Toshinaga Maeda, Hirokazu Inoue, et al.
Cancer Science
|
September 5, 2017
Antitumor effects of eribulin depend on modulation of the tumor microenvironment by vascular remodeling in mouse models
Ken Ito, Shusei Hamamichi, Takanori Abe, et al.
The Journal of Cell Biology
|
June 2, 2010
Laminin-based cell adhesion anchors microtubule plus ends to the epithelial cell basal cortex through LL5alpha/beta
Azusa Hotta, Tomomi Kawakatsu, Tomoya Nakatani, et al.
Nature Communications
|
March 12, 2024
Delivery of a BET protein degrader via a CEACAM6-targeted antibody-drug conjugate inhibits tumour growth in pancreatic cancer models
Youya Nakazawa, Masayuki Miyano, Shuntaro Tsukamoto, et al.
Scientific Reports
|
June 19, 2019
A landmark in drug discovery based on complex natural product synthesis
Satoshi Kawano, Ken Ito, Kenzo Yahata, et al.
Molecular Cancer Therapeutics
|
October 24, 2022
ER-851, a Novel Selective Inhibitor of AXL, Overcomes Resistance to Antimitotic Drugs
Shuntaro Tsukamoto, Naoko Hata Sugi, Kyoko Nishibata, et al.
Page
of 3